Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
基本信息
- 批准号:10632758
- 负责人:
- 金额:$ 37.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-12 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAgeAmericanBlack raceBlood PressureBody mass indexCOVID-19COVID-19 diagnosisCOVID-19 morbidityCOVID-19 mortalityCOVID-19 testCensusesChronic DiseaseClinicalClinical ResearchCodeDataData AnalysesData SetData SourcesDiabetes MellitusDiagnosisEducationElectronic Health RecordEmploymentEthnic OriginFloridaHealthcareHispanicHospitalizationHospitalsHousingIncidenceIncomeIndividualInfectionInpatientsKnowledgeLaboratoriesLinkLow-Density LipoproteinsMethodsMinorityMinority GroupsNon-Insulin-Dependent Diabetes MellitusOutcomeOutpatientsPatientsPersonsPharmaceutical PreparationsPhasePopulationPopulation AnalysisPopulation HeterogeneityPost-Acute Sequelae of SARS-CoV-2 InfectionPredispositionPrevalencePrivatizationProceduresPublic HealthRaceRecommendationRecordsReportingRetrospective cohortRetrospective cohort studyRiskRisk AssessmentRisk FactorsSARS-CoV-2 infectionSARS-CoV-2 negativeSARS-CoV-2 positiveSeveritiesSiteSocial EnvironmentSourceSystemTest ResultTrustUninsuredWomanbaseblocking factorbuilt environmentcardiometabolic riskcare seekingcohortcomputable phenotypescoronavirus diseasedemographicsdiabetes prevention programdiabetes riskethnic differenceethnic diversityethnic minorityevaluation/testingexperiencefollow-uphispanic communitymalemetropolitanminority communitiesmortalitypandemic diseasepatient orientedpatient populationpost SARS-CoV-2 infectionracial and ethnicracial and ethnic disparitiesracial minorityscreeningscreening guidelinessexsocial vulnerabilitystudy populationtelehealthyoung adultyoung woman
项目摘要
PROJECT SUMMARY
Recent reports of type 2 diabetes (T2DM) as a post-acute sequela of SARS-CoV-2 infection (PASC, clinical
findings lasting beyond 30 days of infection) highlight the urgent public health need to better understand and
characterize the potential association between COVID-19 and T2DM. Prior studies of PASC-associated T2DM
among adults living in the US have analyzed data from populations with limited racial/ethnic diversity, making
the results difficult to generalize to Black and Hispanic communities that experience disproportionately higher
rates of SARS-CoV-2 infection, COVID-19-related morbidity and mortality, and T2DM in the US. To advance
our understanding of T2DM risk after SARS-CoV-2 infection in racial and ethnic minority communities, we will
conduct a retrospective cohort study using the OneFlorida+ Data Trust, a Clinical Research Network (CRN)
within the National Patient-Centered Clinical Research Network (PCORnet) that contains patient-level
electronic health record (EHR) data for a diverse population of 19.2 million Americans seeking care in all major
metropolitan regions in Florida (the state with the 3rd highest number of COVID cases in the US) as well as
Atlanta, GA and Birmingham, AL. The association between SARS-CoV-2 infection and incident T2DM has yet
to be empirically quantified by race and/or ethnicity using rigorous methods and relevant variables (social
vulnerability and individual susceptibility factors) for diverse populations, despite the markedly higher rates of
COVID-19 and T2DM in minority communities. We will employ a rigorous analytic approach that utilizes high-
quality data available for both individual susceptibility and social vulnerability factors in the OneFlorida+ Data
Trust, a dataset that includes large proportions of minority groups (24% Hispanic, 18% Black), to address this
critical gap in knowledge. In addition to standard EHR data such as diagnosis/procedure codes, laboratory
values, medications, patient demographics, and vital signs, the OneFlorida+ Data Trust includes linkages to
exposome data on the natural, built, and social environments. Additional strengths of the OneFlorida+ Data
Trust for this project include availability of validated computable phenotypes (CPs) for diabetes to reduce the
chance of outcome misclassification; differentiation of healthcare encounter types; larger proportions of young
adults and women than prior studies of PASC-associated T2DM; diverse payer sources; and the capacity to
link patient records across OneFlorida+ Data Trust contributing sites. Our specific aims are (1) to assess
racial/ethnic differences in PASC-associated T2DM incidence in a retrospective cohort using the OneFlorida+
Data Trust and (2) to compare changes in cardiometabolic risk factors following SARS-CoV-2 infection by
race/ethnicity in a retrospective cohort using the OneFlorida+ Data Trust. This study will fill critical knowledge
gaps in the potential association between COVID-19 and new-onset T2DM in racial and ethnic minority
communities. The findings will directly inform diabetes screening recommendations in the rapidly growing
population of patients experiencing PASC.
项目总结
最近关于2型糖尿病(T2 DM)作为SARS-CoV-2感染的急性后遗症的报道(PASC,临床
发现感染持续30天以上)强调公共卫生迫切需要更好地了解和
描述新冠肺炎与T2 DM之间的潜在关联。PASC相关的T2 DM的研究进展
居住在美国的成年人分析了种族/民族多样性有限的人群的数据,做出了
结果很难推广到黑人和西班牙裔社区,这些社区经历了不成比例的高
美国的SARS-CoV-2感染率、与新冠肺炎相关的发病率和死亡率以及T2 DM。晋级
我们对少数民族社区感染SARS-CoV-2后T2 DM风险的了解,我们将
使用临床研究网络(CRN)One佛罗里达+数据信托进行回溯性队列研究
在以患者为中心的国家临床研究网络(PCORnet)内,该网络包含患者级别
1920万寻求各种主要医疗服务的美国人的电子健康记录(EHR)数据
佛罗里达州的大都会地区(该州的COVID病例数量在美国排名第三)以及
佐治亚州亚特兰大和亚拉巴马州伯明翰SARS-CoV-2感染与2型糖尿病发病的关系尚未见报道
使用严格的方法和相关变量按种族和/或民族进行经验性量化(社会
不同人群的脆弱性和个人易感因素),尽管
新冠肺炎和T2 DM在少数民族社区的流行。我们将使用一种严格的分析方法,利用高
在One佛罗里达+数据中提供个人易感性和社会脆弱性因素的高质量数据
TRUST,一个包括很大比例的少数族裔群体(24%西班牙裔,18%黑人)的数据集,以解决这个问题
知识上的严重差距。除了标准EHR数据,如诊断/程序代码、实验室
价值、药物、患者人口统计和生命体征,One佛罗里达+数据信托包括以下链接
暴露有关自然、建筑和社会环境的数据。One佛罗里达+数据的其他优势
对该项目的信任包括用于糖尿病的有效可计算表型(CP)的可用性,以减少
结果错误分类的机会;医疗保健遭遇类型的差异;年轻人比例较大
成人和女性比先前对PASC相关的T2 DM的研究;不同的支付者来源;以及
跨One佛罗里达+数据信托贡献站点链接患者记录。我们的具体目标是:(1)评估
使用One佛罗里达+的回溯性队列研究中PASC相关T2 DM发病率的种族/民族差异
数据信任和(2)比较SARS-CoV-2感染后心脏代谢危险因素的变化
使用One佛罗里达+数据信托基金的回溯性队列中的种族/民族。这项研究将填补批判性知识
少数民族人群中新冠肺炎与新发T2 DM潜在关联性的研究
社区。这一发现将直接为快速增长的糖尿病筛查建议提供信息
经历PASC的患者群体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rosette J Chakkalakal其他文献
Capsule Commentary on Pilla et al., Predictors of Insulin Initiation in Patients with Type 2 Diabetes: an Analysis of the Look AHEAD Randomized Trial
Pilla 等人的胶囊评论,2 型糖尿病患者胰岛素起始的预测因素:Look AHEAD 随机试验的分析
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:5.7
- 作者:
Rosette J Chakkalakal - 通讯作者:
Rosette J Chakkalakal
Hospitalization Rates for Acute Myocardial Infarction Among Asian-American Subgroups: Have We Been Underestimating the Problem?
亚裔美国人亚群体急性心肌梗死的住院率:我们是否低估了这个问题?
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:1.9
- 作者:
Rosette J Chakkalakal;J. Fox;J. Green;M. Nunez;B. Nallamothu;R. Hasnain - 通讯作者:
R. Hasnain
1643-P: Prevalence of Diabetes Medication Regimens in PCORnet, the National Patient-Centered Clinical Research Network
1643-P:PCORnet(国家以患者为中心的临床研究网络)中糖尿病药物治疗方案的流行率
- DOI:
10.2337/db19-1643-p - 发表时间:
2019 - 期刊:
- 影响因子:7.7
- 作者:
Katherine N. Bachmann;C. Roumie;Andrew D. Wiese;Carlos G. Grijalva;J. Buse;Robert L. Bradford;Emily Zalimeni;Patricia Knoepp;H. Morris;W. Donahoo;Nada Fanous;V. Fonseca;Bonnie L Katalenich;M. Cook;R. Rothman;Rosette J Chakkalakal - 通讯作者:
Rosette J Chakkalakal
Rosette J Chakkalakal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rosette J Chakkalakal', 18)}}的其他基金
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10456167 - 财政年份:2022
- 资助金额:
$ 37.11万 - 项目类别:
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10669641 - 财政年份:2022
- 资助金额:
$ 37.11万 - 项目类别:
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10597811 - 财政年份:2022
- 资助金额:
$ 37.11万 - 项目类别:
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10017683 - 财政年份:2019
- 资助金额:
$ 37.11万 - 项目类别:
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10254280 - 财政年份:2019
- 资助金额:
$ 37.11万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.11万 - 项目类别:
Research Grant














{{item.name}}会员




